An increase in gilt yields in 2013 could push up the price of buy-ins but improve the affordability of full buyouts, says Pension Corporation.
Hymans Robertson longevity consultant Andrew Gaches explores the latest trends in life expectancy.
Rothesay Life co-head of business development Guy Freeman examines the role annuities can play in a portfolio.
Aon Hewitt partner Kevin Wesbroom explains why schemes are no nearer their long-term goals than they were five years ago.
JLT Pension Capital Strategies head of buyouts Martyn Phillips looks at how medically underwritten bulk annuity deals could cut the cost of de-risking.
Pension Corporation co-head of business origination David Collinson explains what trustees can learn from approaches to liability-driven investment taken by insurers.
The Willis Group pension scheme has adopted PensionsFirst's PFaroe platform to manage risks in its £1.3bn scheme.
The Pensions Regulator has denied it is forcing trustees to use a gilt-based mechanism to measure liabilities, in the face of calls to be more flexible on valuations.
More than a dozen schemes are undertaking medically underwritten buy-ins with Partnership, after the first two ‘enhanced' buy-ins were completed by the insurer last year.
The vast majority of schemes now have a clear long-term objective, but unfortunately for most that destination is getting further away, says Aon Hewitt.